Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000815

Director sold 88,011 shares at $19.79 ($1,741,738)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
EMSTER KURT VON Director 2017-08-28 Sale −88,011 $19.79 $1,741,738 1,951,359 I: show line 1 in the form
Open-market sales · 88,011 sh · avg $19.79 · $1,741,738
Loading xslF345X03/vonemster_form4aug282017.xml…